Goldan Keith A. (CIK 0001495411)

Latest company ownership

SNDX - Syndax Pharmaceuticals Inc

Role: CFO

Shares held

92,452

Last filed at

Dec 1, 2025

Confidence Score

54.6

2025Q4

Confidence Score History

2023Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 31, 2025	Aug 7, 2025	Syndax Pharmaceuticals Inc	CFO	Buy	78.8	+1,226	1.33%	✗	$10.3K
Jul 16, 2025	Jul 18, 2025	Syndax Pharmaceuticals Inc	CFO	Sell	46.3	-1,296	-1.38%	✗	$12K
Feb 10, 2025	Feb 12, 2025	Syndax Pharmaceuticals Inc	CFO	Sell	42.5	-3,777	-4.00%	✗	$58.6K
Jun 14, 2024	Jun 17, 2024	Syndax Pharmaceuticals Inc	CFO	Buy	78.8	+1,250	2.43%	✗	$25K
Jul 31, 2023	Feb 9, 2024	Syndax Pharmaceuticals Inc	CFO	Buy	91.3	+48,745	1854.83%	✗	$36.2K
Jun 13, 2023	Jun 14, 2023	Syndax Pharmaceuticals Inc	CFO	Sell	46.3	-577	-18.00%	✗	$12.9K